Name | Type | Posted | Actions |
|---|---|---|---|
https://acquisition.army.mil/asfi/solicitation_view.cfm?psolicitationnbr=W81XWH12T0119 | LINK | Feb 29, 2012 | |
https://acquisition.army.mil/asfi/solicitation_view.cfm?psolicitationnbr=W81XWH12T0119 | LINK | Feb 28, 2012 | |
https://acquisition.army.mil/asfi/solicitation_view.cfm?psolicitationnbr=W81XWH12T0119 | LINK | Feb 13, 2012 | |
https://acquisition.army.mil/asfi/solicitation_view.cfm?psolicitationnbr=W81XWH12T0119 | LINK | Feb 6, 2012 | |
https://acquisition.army.mil/asfi/solicitation_view.cfm?psolicitationnbr=W81XWH12T0119 | LINK | Feb 1, 2012 | |
https://acquisition.army.mil/asfi/solicitation_view.cfm?psolicitationnbr=W81XWH12T0119 | LINK | Jan 30, 2012 |
68--Synthetic Cannabinoids IDIQ Contract
Contact and place of performance
Colleen Barnes, 301-619-9599 US Army Medical Research Acquisition Activity
Not specified
No narrative description provided for this notice.
The US Army Medical Research Acquisition Activity is soliciting proposals for an Indefinite Delivery Indefinite Quantity (IDIQ) contract regarding synthetic cannabinoids. This requirement is classified under NAICS code 325199, All Other Basic Organic Chemical Manufacturing, and Product Service Code 68. The procurement is designated as an SBA (SBA) set-aside.
Responses to solicitation number W81XWH12T0119 are due by March 1, 2012. The notice was originally published on January 30, 2012, and last updated on February 29, 2012. Colleen Barnes is the primary point of contact for this opportunity at the US Army Medical Research Acquisition Activity.
Generated by Lumen AI
Scoped analysis and attachments—go beyond the summary when you need detail from the solicitation package.